About this trial

The purpose of this study is to evaluate the use of Cereset Research to improve autonomic function in participants with symptoms of stress, anxiety, or insomnia.

Eligibility criteria

Qualifiers

Subjects must have the ability to comply with basic instructions and be able to sit still comfortably with the sensor leads attached

Subjects experiencing symptoms of stress, anxiety, or insomnia, who meet threshold scores on one or more self-reported inventories for the same. This includes the Insomnia Severity Index (ISI, ≥ 8), the Perceived Stress Index (PSS, ≥ 14), or the Generalized Anxiety Disorder 7-item (GAD-7, ≥ 5) scale.

Disqualifiers

Unable, unwilling, or incompetent to provide informed consent/assent.

Physically unable to come to the study visits, or to sit comfortably in a chair for up to 1.5 hours.

Severe hearing impairment (because the subject will be using ear buds during CR).

Weight is over the chair limit (285 pounds).

Trial design

Treatments tested in this trial

  • Active CR

Treatment groups

200 Participants
are divided into 1 treatment group

Locations

1
Wake Forest University Health Scienc\ess27157, Winston-SalemNorth Carolina, United States

Sponsors and collaborators

Wake Forest University Health Sciences

Lead sponsor